Table S6.
Patients’ features according to HCV treatment
| Patients’ main features | SOF+RBV | SOF+LDP+RBV | SOF+SIM+RBV | PTVr/OBV+DSV+RBV | SOF+DCV+RBV | SOF+SIM | SOF+LDP | PTVr/OBV+RBV | PTVr/OBV+DSV | SOF+DCV | p-value |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||||
| n=76 | n=52 | n=51 | n=44 | n=36 | n=26 | n=16 | n=10 | n=9 | n=7 | ||
| Age, years | 55 (51–71) | 55 (52–59) | 55 (52–61) | 55 (51–63) | 55 (52–55) | 57 (51–62) | 56 (51–64) | 54 (51–59) | 56 (51–60) | 57 (54–62) | 0.43 |
| Gender (male) | 55 (72.73) | 41 (78.85) | 38 (774.51) | 32 (72.73) | 31 (86.11) | 8 (30.77) | 13 (81.25) | 7 (70.00) | 4 (44.44) | 4 (57.14) | <0.0001 |
| Fibrosis stage | <0.0001 | ||||||||||
| 1 | 1 (1.32) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 1 (3.85) | 1 (6.25) | 0 (0.00) | 1 (11.11) | 0 (0.00) | |
| 2 | 1 (1.32) | 0 (0.00) | 1 (1.96) | 0 (0.00) | 0 (0.00) | 1 (3.85) | 2 (12.50) | 0 (0.00) | 0 (0.00) | 1 (14.29) | |
| 3 | 19 (25.00) | 2 (3.85) | 8 (15.69) | 6 (13.64) | 1 (2.87) | 9 (34.62) | 7 (43.75) | 4 (40.00) | 6 (66.67) | 2 (28.57) | |
| 4 | 55 (72.37) | 50 (96.15) | 42 (82.35) | 38 (86.36) | 35 (97.22) | 15 (57.69) | 6 (37.50) | 6 (60.00) | 2 (22.22) | 4 (57.14) | |
| Genotype | <0.0001 | ||||||||||
| 1 | 0 (0.00) | 45 (86.54) | 38 (74.51) | 44 (100.00) | 3 (8.33) | 21 (80.77) | 12 (75.00) | 0 (0.00) | 9 (100.00) | 2 (28.57) | |
| 2 | 31 (40.79) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | |
| 3 | 45 (59.21) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 29 (80.56) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 4 (57.14) | |
| 4 | 0 (0.00) | 7 (13.46) | 13 (25.49) | 0 (0.00) | 4 (11.11) | 5 (19.23) | 4 (25.00) | 10 (100.00) | 0 (0.00) | 1 (14.29) | |
| Comorbidities | 37 (48.68) | 39 (75.00) | 27 (52.94) | 22 (50.00) | 24 (66.67) | 4 (15.38) | 7 (43.75) | 2 (20.00) | 2 (22.22) | 4 (57.14) | <0.0001 |
| Previous treatment HCV | 35 (46.05) | 29 (55.77) | 37 (72.55) | 27 (61.36) | 18 (50.00) | 7 (26.92) | 5 (31.25) | 4 (40.00) | 8 (88.89) | 4 (57.14) | 0.002 |
Note: Data are presented as median (interquartile range) for continuous variables and as frequency (%) for categorical variables.
Abbreviations: DCV, daclatasvir; DSV, dasabuvir; HCV, hepatitis C virus; LDP, ledipasvir; OBV, ombitasvir; PTVr, ritonavir boosted paritaprevir; RBV, ribavirin; SIM, simeprevir; SOF, sofosbuvir.